50 related articles for article (PubMed ID: 38474751)
1. Targeting metabolic reprogramming to overcome drug resistance in advanced bladder cancer: insights from gemcitabine- and cisplatin-resistant models.
Kawahara I; Yoshino H; Fukumoto W; Arima J; Saito S; Li G; Fukuda I; Mitsuke A; Sakaguchi T; Inoguchi S; Matsushita R; Nakagawa M; Tatarano S; Yamada Y; Enokida H
Mol Oncol; 2024 Jun; ():. PubMed ID: 38874588
[TBL] [Abstract][Full Text] [Related]
2. Targeting Chemoresistance in Advanced Bladder Cancers with a Novel Adjuvant Strategy.
Seremak JR; Gupta KB; Bonigala S; Liu E; Marshall B; Zhi W; Bokhtia RM; Panda SS; Lokeshwar VB; Lokeshwar BL
Mol Cancer Ther; 2024 May; ():. PubMed ID: 38814440
[TBL] [Abstract][Full Text] [Related]
3. Sulforaphane Impact on Reactive Oxygen Species (ROS) in Bladder Carcinoma.
Xie H; Chun FK; Rutz J; Blaheta RA
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073079
[TBL] [Abstract][Full Text] [Related]
4. Sulforaphane Inhibits Adhesion and Migration of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro.
Xie H; Rutz J; Maxeiner S; Grein T; Thomas A; Juengel E; Chun FK; Cinatl J; Haferkamp A; Tsaur I; Blaheta RA
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474751
[TBL] [Abstract][Full Text] [Related]
5. Bladder Cancer Metastasis Induced by Chronic Everolimus Application Can Be Counteracted by Sulforaphane In Vitro.
Justin S; Rutz J; Maxeiner S; Chun FK; Juengel E; Blaheta RA
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759798
[TBL] [Abstract][Full Text] [Related]
6. Plant-Derived Sulforaphane Suppresses Growth and Proliferation of Drug-Sensitive and Drug-Resistant Bladder Cancer Cell Lines In Vitro.
Xie H; Rutz J; Maxeiner S; Grein T; Thomas A; Juengel E; Chun FK; Cinatl J; Haferkamp A; Tsaur I; Blaheta RA
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230603
[TBL] [Abstract][Full Text] [Related]
7. Allyl-, Butyl- and Phenylethyl-Isothiocyanate Modulate Akt-mTOR and Cyclin-CDK Signaling in Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell Lines.
Rutz J; Maxeiner S; Grein T; Sonnenburg M; Khadir SE; Makhatelashvili N; Mann J; Xie H; Cinatl J; Thomas A; Chun FK; Haferkamp A; Blaheta RA; Tsaur I
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232303
[TBL] [Abstract][Full Text] [Related]
8. Sulforaphane-cisplatin combination inhibits the stemness and metastatic potential of TNBCs via down regulation of sirtuins-mediated EMT signaling axis.
Sinha S; Sharma S; Sharma A; Vora J; Shrivastava N
Phytomedicine; 2021 Apr; 84():153492. PubMed ID: 33640782
[TBL] [Abstract][Full Text] [Related]
9. Amygdalin influences bladder cancer cell adhesion and invasion in vitro.
Makarević J; Rutz J; Juengel E; Kaulfuss S; Tsaur I; Nelson K; Pfitzenmaier J; Haferkamp A; Blaheta RA
PLoS One; 2014; 9(10):e110244. PubMed ID: 25333694
[TBL] [Abstract][Full Text] [Related]
10. E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies.
Wang M; Zhang Z; Li Z; Zhu Y; Xu C
Front Immunol; 2023; 14():1226057. PubMed ID: 37497216
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic review of sulforaphane as a chemoprotective agent in bladder cancer.
Kennelley GE; Amaye-Obu T; Foster BA; Tang L; Paragh G; Huss WJ
Am J Clin Exp Urol; 2023; 11(2):103-120. PubMed ID: 37168941
[TBL] [Abstract][Full Text] [Related]
12. Pacsin 2-dependent N-cadherin internalization regulates the migration behaviour of malignant cancer cells.
Wint H; Li J; Abe T; Yamada H; Higaki T; Nasu Y; Watanabe M; Takei K; Takeda T
J Cell Sci; 2023 May; 136(10):. PubMed ID: 37132654
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity.
Tomooka F; Kaji K; Nishimura N; Kubo T; Iwai S; Shibamoto A; Suzuki J; Kitagawa K; Namisaki T; Akahane T; Mitoro A; Yoshiji H
Cells; 2023 Feb; 12(5):. PubMed ID: 36899823
[TBL] [Abstract][Full Text] [Related]
14. Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transition.
Monteiro-Reis S; Miranda-Gonçalves V; Guimarães-Teixeira C; Martins-Lima C; Lobo J; Montezuma D; Dias PC; Neyret-Kahn H; Bernard-Pierrot I; Henrique R; Jerónimo C
Int J Biol Sci; 2023; 19(1):1-12. PubMed ID: 36594099
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
